---
title: "First patient enrolled in continued access protocol trial of heart transplant technology"
date: "2025-07-22T09:11:58.000Z"
publishedDate: "22 juillet 2025"
summary: "Xvivo has announced that the first patient has been enrolled as part of the continued access protocol (CAP) study for its heart technology, Xvivo Heart Assist Transport, in the USA. This CAP study follows the PRESERVE trial and allows for the enrolment of up to 60 patients across 26 US transplant centres."
importance: ""
sourceUrl: "https://cardiovascularnews.com/first-patient-enrolled-in-continued-access-protocol-trial-of-heart-transplant-technology/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-07-22-first-patient-enrolled-in-continued-access-protocol-trial-of-heart-transplant-technology"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/07/XVIVO-Heart-Assist-Transport.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-patient-enrolled-in-continued-access-protocol-trial-of-heart-transplant-technology/"
---

![First patient enrolled in continued access protocol trial of heart transplant technology](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/07/XVIVO-Heart-Assist-Transport.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-patient-enrolled-in-continued-access-protocol-trial-of-heart-transplant-technology/*

## L’essentiel

Xvivo has announced that the first patient has been enrolled as part of the continued access protocol (CAP) study for its heart technology, Xvivo Heart Assist Transport, in the USA. This CAP study follows the PRESERVE trial and allows for the enrolment of up to 60 patients across 26 US transplant centres.

## Lien source

https://cardiovascularnews.com/first-patient-enrolled-in-continued-access-protocol-trial-of-heart-transplant-technology/
